Advanced Telemonitoring of Patients With COPD in Home Environment

NCT05269043 | Completed

• 1 other identifier: SHAPES UC-PT3-COPD
• Study Type: observational
• Target: 25
• Locations: 1 country
• Sites: 1

Brief Summary

Chronic obstructive pulmonary disease (COPD) is one of the leading and rising causes of morbidity and mortality worldwide. The most important etiopathogenetic agent is smoking. However, air-pollution probably also plays a crucial role in the disease development, progression and exacerbations. The multimodal-telemedicine approach may provide a useful tool in the patient follow-up with the aim to reduce disease exacerbation rate and improve the health-related quality of life. The study aims to investigate the effects and utility of advanced telemonitoring in elderly COPD patients. All data will be integrated in a single web-based platform in order to analyse the mutual effects of different conditions and variables.

Conditions

COPD

Outcome Measures

Primary Outcomes (9)

• Telemetric spirometry - FVC

  Evaluation of telemetric measurement of FVC in home enviroment in COPD patients wih use of mobile spirometer

  3 month

• Telemetric spirometry - PEF

  Evaluation of telemetric measurement of PEF in home enviroment in COPD patients wih use of mobile spirometer

  3 month

• Telemetric spirometry - FEV1%

  Evaluation of telemetric measurement of FEV1% in home enviroment in COPD patients wih use of mobile spirometer

  3 month

• Telemetric spirometry - FEV1%/FVC ratio

  Evaluation of telemetric measurement of FEV1%/FVC ratio in home enviroment in COPD patients wih use of mobile spirometer

  3 month

• Blood oxygen saturation monitoring

  Continuous measurement of blood oxygen saturation in the study group.

  3 month

• Particulate matter concentration monitoring

  Continuous measurement of both indoor and outdoor air-pollution levels via monitoring of selected parameters (PM1.0, PM2.5, PM4.0, PM10). and some other selected environmental parameters (humidity and temperature) - as well in both outdoor and indoor conditions.

  3 month

• Environmental monitoring

  Continuous measurement of selected environmental parameters (humidity and temperature) - in both outdoor and indoor conditions.

  3 month

• Adherence monitoring - rate of inhalations per day

  The regular monitoring of the patients' adherence to the inhaled therapy, using FindAir smart inhaler technology. Rate of inhalations per day is measured via special cap mounted on the top of the inhaler which is detecting each activation while pressing the cap. Result is being compared with the amount of inhalations recommended by the physician.

  3 month

• Adherence monitoring - time of inhalation deviation

  The regular monitoring of the patients' adherence to the inhaled therapy, using FindAir smart inhaler technology. A specific time of inhalation is being recorded by a special cap mounted on the top of the inhaler which is detecting each activation while pressing the cap. Deviation between recommended time of inhalation and real time of inhalation is being monitored through the study.

  3 month

Interventions

Medimonitor DEVICE

A digital solution consisting of smartphone/tablet based application gathering data from medical and other devices provided to the patients. These devices are as follows: tablet, smart inhaler, spirometer, blood pressure monitor, pulse oximetry device, particulate matter sensor.

Eligibility Criteria

• Age: 60 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients with chronic obstructive pulmonary disease.

You may qualify if:

• COPD
• ≥ 60 years of age
• Informed written and verbal consent
• Ability to participate in study activities

You may not qualify if:

• Active smoking
• Respiratory failure requiring oxygenotherapy or ventilation support
• Severe psychological disturbances
• Absence of collaboration (informed consent)
• Other comorbid pulmonary disease
• Symptomatic heart failure
• Motor neuron diseases (e.g. amyotrophic lateral sclerosis etc.)

Sponsors & Collaborators

• University Hospital Olomouc: lead

Study Sites (1)

Department of Respiratory Medicine, University Hospital Olomouc, Czech Republic

Olomouc, 77900, Czechia

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: January 31, 2022
• First Posted: March 7, 2022
• Study Start: October 14, 2022
• Primary Completion: February 1, 2023
• Study Completion: February 1, 2023
• Last Updated: January 29, 2024

Record last verified: 2024-01

Data Sharing

• IPD Sharing: Will not share

Locations

CZ (1)